[1]CHRISTAKOS S,DHAWAN P,VERSTUYF A,et al.Vitamin D:metabolism,molecular mechanism of action,and pleiotropic effects[J].Physiological Reviews,2016,96(1):365-408.
[2]NAKAMURA K,SMYTH MJ.Targeting cancer-related inflammation in the era of immunotherapy[J].Immunology and Cell Biology,2017,95(4):325-332.
[3]GEMBILLO G,CERNARO V,SALVO A,et al.Role of vitamin D status in diabetic patients with renal disease[J].Medicina(Kaunas,Lithuania),2019,55(6):273.
[4]ZHOU W,WANG Q.Vitamin D suppresses lipopolysaccharide-induced inflammatory response in vascular smooth muscle cells via inhibition of the p38 MAPK signaling pathway[J].Die Pharmazie,2019,74(3):168-174.
[5]LIN Z,LI W.The roles of vitamin D and its analogs in inflammatory diseases[J].Current Topics in Medicinal Chemistry,2016,16(11):1242-1261.
[6]CASTELLANO-CASTILLO D,MORCILLO S,CLEMENTE-POSTIGO M,et al.Adipose tissue inflammation and VDR expression and methylation in colorectal cancer[J].Clin Epigenetics,2018,10:60.
[7]FERRER-MAYORGA G,LARRIBA MJ,CRESPO P,et al.Mechanisms of action of vitamin D in colon cancer[J].The Journal of Steroid Biochemistry and Molecular Biology,2019,185:1-6.
[8]YANG L,WU L,ZHANG X,et al.1,25(OH)2D3/VDR attenuates high glucose-induced epithelial-mesenchymal transition in human peritoneal mesothelial cells via the TGFβ/Smad3 pathway[J].Molecular Medicine Reports,2017,15(4):2273-2279.
[9]CZARES-ORDOEZ V,GONZLEZ-DUARTE RJ,DAZ L,et al.A cis-acting element in the promoter of human ether à go-go 1 potassium channel gene mediates repression by calcitriol in human cervical cancer cells[J].Biochemistry and Cell Biology,2015,93(1):94-101.
[10]KIZILDAG S,ATES H,KIZILDAG S.Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2,BAX,BCLXL,and p21[J].Ann Hematol,2010,89(1):1-7.
[11]KIM TH,PARK J,LEE JS,et al.Effects of 1alpha,25-dihydroxyvitamin D(3) on programmed cell death of Ishikawa endometrial cancer cells through ezrin phosphorylation[J].Journal of Obstetrics and Gynaecology,2017,37(4):503-509.
[12]SERGEEV IN.Vitamin D status and vitamin D-dependent apoptosis in obesity[J].Nutrients,2020,12(5):1392.
[13]BROZYNA AA,JOZWICKI W,JETTEN AM,et al.On the relationship between VDR,RORα and RORγ receptors expression and HIF1-α levels in human melanomas[J].Experimental Dermatology,2019,28(9):1036-1043.
[14]AGGARWAL A,FELDMAN D,FELDMAN BJ.Identification of tumor-autonomous and indirect effects of vitamin D action that inhibit breast cancer growth and tumor progression[J].The Journal of Steroid Biochemistry and Molecular Biology,2018,177:155-158.
[15]BOKHARI AA,LEE LR,RABOTEAU D,et al.Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1[J].Oncotarget,2016,7(47):77576-77590.
[16]LONG M,ROJO DE LA VEGA M,WEN Q,et al.An essential role of NRF2 in diabetic wound healing[J].Diabetes,2016,65(3):780-793.
[17]赵钦,杨志勇,庄则豪.维生素D的抗肿瘤作用与食管癌[J].肿瘤代谢与营养电子杂志,2017,4(03):258-262.
ZHAO Q,YANG ZY,ZHUANG ZH.The antitumor effect of vitamin D and esophageal cancer[J].Electronic Journal of Tumor Metabolism and Nutrition,2017,4(03):258-262.
[18]COLONESE F,LAGAN AS,COLONESE E,et al.The pleiotropic effects of vitamin D in gynaecological and obstetric diseases:an overview on a hot topic[J].BioMed Research International,2015,2015:986281.
[19]杨伟杰,赵伟鑫,刘永亮,等.维生素D受体研究进展[J].河南科技学院学报(自然科学版),2019,47(05):46-51.
YANG WJ,ZHAO WX,LIU YL,et al.Research progress of vitamin D receptor[J].Journal of Henan University of Science and Technology(Natural Science Edition),2019,47(05):46-51.
[20]LISSE TS,HEWISON M,ADAMS JS.Hormone response element binding proteins:novel regulators of vitamin D and estrogen signaling[J].Steroids,2011,76(4):331-339.
[21]LA MARRA F,STINCO G,BULIGAN C,et al.Immunohistochemical evaluation of vitamin D receptor(VDR) expression in cutaneous melanoma tissues and four VDR gene polymorphisms[J].Cancer Biology & Medicine,2017,14(2):162-175.
[22]DEUSTER E,JESCHKE U,YE Y,et al.Vitamin D and VDR in gynecological cancers-a systematic review[J].International Journal of Molecular Sciences,2017,18(11):2328.
[23]GUO H,GUO J,XIE W,et al.The role of vitamin D in ovarian cancer:epidemiology,molecular mechanism and prevention[J].Journal of Ovarian Research,2018,11(1):71.
[24]HOU YF,GAO SH,WANG P,et al.1α,25(OH)2D3 suppresses the migration of ovarian cancer SKOV-3 cells through the inhibition of epithelial-mesenchymal transition[J].International Journal of Molecular Sciences,2016,17(8):1285.
[25]LUNGCHUKIET P,SUN Y,KASIAPPAN R,et al.Suppression of epithelial ovarian cancer invasion into the omentum by 1α,25-dihydroxyvitamin D3 and its receptor[J].The Journal of Steroid Biochemistry and Molecular Biology,2015,148:138-147.
[26]CHEN Y,SUN Z,XU J,et al.Vitamin D and DDX4 regulate the proliferation and invasion of ovarian cancer cells[J].Oncology Letters,2018,16(1):905-909.
[27]JAVADI S,GANESHAN DM,QAYYUM A,et al.Ovarian cancer,the revised FIGO staging system,and the role of imaging[J].American Journal of Roentgenology,2016,206(6):1351-1360.
[28]AHONEN MH,ZHUANG YH,AINE R,et al.Androgen receptor and vitamin D receptor in human ovarian cancer:growth stimulation and inhibition by ligands[J].International Journal of Cancer,2000,86(1):40-46.
[29]LACZMANSKI L,LWOW F,OSINA A,et al.Association of the vitamin D receptor FokI gene polymorphism with sex-and non-sex-associated cancers:A meta-analysis[J].Tumour Biology,2017,39(10):1010428317727164.
[30]YABUSHITA H,HIRATA M,NOGUCHI M,et al.Vitamin D receptor in endometrial carcinoma and the differentiation-inducing effect of 1,25-dihydroxyvitamin D3 on endometrial carcinoma cell lines[J].The Journal of Obstetrics and Gynaecology Research,1996,22(6):529-539.
[31]AGIC A,XU H,ALTGASSEN C,et al.Relative expression of 1,25-dihydroxyvitamin D3 receptor,vitamin D 1 alpha-hydroxylase,vitamin D 24-hydroxylase,and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers[J].Reproductive Sciences(Thousand Oaks,Calif.),2007,14(5):486-497.
[32]LEE LR,TENG PN,NGUYEN H,et al.Progesterone enhances calcitriol antitumor activity by upregulating vitamin D receptor expression and promoting apoptosis in endometrial cancer cells[J].Cancer Prevention Research(Philadelphia,Pa.),2013,6(7):731-743.
[33]KUITTINEN T,ROVIO P,STAFF S,et al.Paclitaxel,carboplatin and 1,25-D3 inhibit proliferation of endometrial cancer cells in vitro[J].Anticancer Research,2017,37(12):6575-6581.
[34]曹蕾,上官改珍,白雯.1,25-(OH)2D3在宫颈良性病变和宫颈癌患者中的表达水平及临床意义[J].实用癌症杂志,2019,34(09):1409-1411.
CAO L,SHANGGUAN GZ,BAI W.The expression level and clinical significance of 1,25-dihydroxyvitamin D3 in patients with cervical benign lesions and cervical cancer[J].Journal of Practical Cancer,2019,34(09):1409-1411.
[35]VAHEDPOOR Z,JAMILIAN M,BAHMANI F,et al.Effects of long-term vitamin D supplementation on regression and metabolic status of cervical intraepithelial neoplasia:a randomized,double-blind,placebo-controlled trial[J].Hormones & Cancer,2017,8(1):58-67.
[36]WANG G,LEI L,ZHAO X,et al.Calcitriol inhibits cervical cancer cell proliferation through downregulation of HCCR1 expression[J].Oncology Research,2014,22(5-6):301-309.
[37]AVILA E,GARCA-BECERRA R,RODRGUEZ-RASGADO JA,et al.Calcitriol down-regulates human ether a go-go 1 potassium channel expression in cervical cancer cells[J].Anticancer Research,2010,30(7):2667-2672.
[38]SALEHIN D,HAUGK C,THILL M,et al.Vitamin D receptor expression in patients with vulvar cancer[J].Anticancer Research,2012,32(1):283-289.